To determine the potential of RNA for transient expression, we followed its translational efficiency and expression kinetics in vivo in mouse skin. Three RNA species were delivered in vivo with differing 5 0 and 3 0 ends, as well as with different structures that are known to influence their translation fate, such as an internal ribosome entry site (IRES), a cap or a poly(A) tail. RNAs were transferred by electropermeabilization, and each encoded the firefly luciferase enzyme to allow monitoring of translational efficiency by in vivo bioluminescence imaging. We show that all types of naked RNAs delivered into mouse skin are efficient for transient protein expression in vivo. Expression could be achieved with some differences in efficiency and time course, using either capped/ polyadenylated RNAs or RNAs containing HCV IRES structures with or without a poly(A) tail. Our data reveal expression occurring up to 2 weeks, suggesting that electroporated RNA has high stability in vivo, particularly capped and polyadenylated RNAs. Our study shows that RNA molecules are efficient tools for the transient expression of proteins in vivo and that they can be used for therapeutic purposes. Changes in RNA features may be used to modulate both expression efficiency and kinetics.
INTRODUCTION
Gene therapy aims to deliver genetic material into somatic cells to either restore the normal expression of a defective gene or express a therapeutic one. The choice of transgene vector is a critical aspect for this therapeutic approach. The use of messenger RNA (mRNA) as a vector for genetic information has recently become an interesting and alternative strategy to naked DNA for the treatment of genetic disorders or vaccination. 1, 2 RNA has long been considered an unstable genetic tool in vivo because intracellular and extracellular RNases were believed to impair its efficiency. However, naked mRNA offers several advantages relative to their DNA equivalent. mRNA delivery is safe because it does not integrate into the host genome, precluding any insertion-based mutagenesis problems. In addition, expression is transient due to the relatively short half-life of RNA molecules. Crossing the nuclear membrane remains a major barrier for plasmid DNA expression, but mRNA does not require entry into the nucleus for translation. Consequently, strong and early protein expression has been observed from mRNA after electroporation in vitro. 3, 4 In addition, mRNA-based transfection efficiency is independent of cell cycle, yielding a high percentage of transfected cells, even in slowly dividing cells. For example, the mRNA electroporation efficiency of dendritic cells in vitro was B95% and thus appeared to be more effective than DNA transfer. 5 The immunogenicity of plasmid DNA is also a major concern: unmethylated DNA CpG motifs induce a strong immune response through Toll-like receptor 9 (TLR9). [6] [7] [8] In contrast to plasmid DNA, mRNA is devoid of immunogenic CpG motifs. It has been shown that mRNA encoding a reporter gene, such as Firefly luciferase (LucF) or beta-galactosidase, did not elicit any detectable, specific immune response. 9 However, if intentionally engineered to encode immunogenic proteins, transcribed mRNA may cause strong immune responses through TLR7 and TLR8. [10] [11] [12] [13] Mature eukaryotic mRNA exhibits a tripartite structure, consisting of a 5 0 untranslated region (5 0 UTR), an open-reading frame and a 3 0 untranslated region. Cytoplasmic mRNA also contains a cap structure (m7Gp3N (N: any nucleotide)) at its 5 0 end and a tail of 100-250 adenosine residues (poly(A) tail) at its 3 0 terminus. Translation in eukaryotic cells occurs through two different mechanisms that are named according to the initiation step: cap-dependent and internal ribosome entry site (IRES)-dependent translation. In cap-dependent translation, the 40S ribosomal small subunit binds to the 5 0 terminal cap through the eIF4F complex and scans the 5 0 UTR (from 5 0 to 3 0 ) until it recognizes the initiation codon. Interactions between the poly(A) tail and the cap structure are required for cap-dependent translation. In contrast, initiation occurs directly at a specific site within the mRNA during IRESdependent translation, making translation independent of the cap structure. IRES-dependent translation was first demonstrated for RNA of viral origin that did not have cap structures. 14, 15 Some of the eIFs, including eIF4F, are not required for IRES-dependent translation of viral RNA in eukaryotic cells, 16 and the 40S ribosomal subunit is directly recruited by the structure of RNA. Viral IRESs are highly efficient for translation in eukaryotic cells and are thus extensively used as molecular tools to ensure a high rate of exogenous protein synthesis from both mono-and pluri-cistronic constructs. IRES-dependent translation has also been identified in cellular mRNAs of endogenous origin (eukaryotic IRESs). In eukaryotic cells, cap-dependent translation remains the major translational mechanism, but IRES-dependent translation of cellular mRNA has important roles at specific times when capdependent translation is severely repressed, helping to maintain the synthesis of a subset of important cell survival proteins.
For example, a switch from cap-to IRES-dependent translation occurs during mitosis, and defects in this mitotic translational switch are related to genomic instability and tumorigenesis. 19 The switch to IRES-dependent translation is the result of multiple events that lead to disruption of the eIF4F complex. 18 Considering that the aforementioned benefits of RNAs increase their potential to become therapeutic molecules for gene therapy, the aim of the present work is to evaluate different RNA species for their expression efficiency in vivo. These RNAs differ in their 5 0 and 3 0 ends and incorporate different structures, such as an IRES, a cap or a poly(A) tail, to direct their translation fate. Naked RNA was transferred into the cell after cell permeability was induced by electropermeabilization (EP) in mouse skin. The RNAs encoded the LucF reporter gene to non-invasively enable in vivo monitoring of translation efficiency by bioluminescence imaging (BLI). Altogether, our data provide information on the in vivo translational efficiency and kinetics of different RNA species.
RESULTS AND DISCUSSION
Three RNA species were used to study the effects of RNA sequence and structural elements on in vivo translational efficiency. They all encode the LucF reporter gene but had different 3 0 and 5 0 end compositions and varying structures ( Figure 1 ). The cap-LucF-polyA RNA contained a 5 0 cap structure and a 3 0 poly(A) tail to be translated by the cap-dependent pathway. The IRES-LucF-3UTR RNA contained both the 3 0 and 5
0
UTRs of HCV, and translation utilized the IRES structure within the 5 0 UTR. The IRES-LucF-polyA RNA contained the 5 0 UTR of HCV within the IRES structure and a poly(A) tail at the 3 0 end. Based on previously reported data using an RNA-based vaccine via intra-dermal EP, 9 14 Â 10 12 molecules of RNA (B5 mg) were used. Each RNA species was injected into an intra-dermal location in the left leg of mice, and transcutaneous electric pulses were immediately applied. After RNA EP, LucF expression was followed by measuring luciferase activity using BLI.
As shown in Figures 2a-c, cap-LucF-polyA RNA was efficiently expressed in the skin. Maximum LucF expression was observed B20 h after EP, but there was significant heterogeneity in both BLI signal intensity and duration. Differences in LucF expression varied up to 10 times in expression level. For mice with the highest expression level, the BLI signal remained detectable for up to 2 weeks, as shown in Figures 2a and c. No dose effect was detected in increasing or decreasing the dose of RNA injected by 3.5-fold, but the cases with very high rate and long-term luciferase expression were not observed ( Figure 2d ). Figures 3 and 4 show that IRES-LucF-3UTR and IRES-LucF-polyA RNAs were also expressed in vivo after EP. In both cases, expression levels peaked B18 h after EP and declined thereafter. For IRES-LucF-3UTR RNA, the BLI signal almost completely disappeared 3 days after EP, whereas it persisted up to 5 days with IRES-LucF-polyA. For these two RNA species, injection of 44 Â 10 12 RNAs increased the BLI signal at 20 h after EP ( Figures  3c and 4c ). Figure 5 shows that cap-LucF-polyA RNA appeared to be the most efficient RNA species for both signal intensity and duration of transient expression in vivo.
The detection of the BLI signal for several days after RNA EP indicated the persistence of functional RNAs within the targeted tissues. This hypothesis was further supported by the following: LucF did not require post-translational modification of the translated protein to exhibit enzymatic activity, the half-life of LucF was B3 h, 20 and in vivo detection of LucF enzymatic activity did not exceed 24 h after transient transcription of RNA. 21 Thus, BLI signal was a reliable indicator of RNA translation. 22 This finding challenged the presumed instability of RNA in vivo; our data may imply the existence of mechanisms providing high in vivo stability of different electroporated RNA molecules. Cap-LucF-polyA RNAs remained translatable for up to 2 weeks; in contrast, non-capped/ non-polyadenylated RNAs, such as IRES-LucF-3UTR, remained for B3 days. Maximum LucF expression occurred during the first day following RNA EP, and then decreased slowly as the RNA pool was expected to decrease. Our current in vivo experiment did not provide any information on the potential mechanisms for RNA preservation in vivo. Long-term stability has already been reported for RNA of maternal origin in mouse oocytes. 23 Although maternal RNAs in oocytes were translationally dormant, the electroporated RNAs used in this study were efficiently translated. Furthermore, mRNA storage has already been reported in intracellular aggregates named P bodies, including a possible return to translation. 24, 25 Cap-LucF-polyA RNAs appeared to be the most efficient RNA species for transient expression in vivo. These data corroborated in vitro experiments showing cap-LucF-polyA efficiency for LucF expression to be 2 times more effective than IRES-LucF-polyA and 24 times more effective than IRES-LucF-3UTR (Supplementary Figure 1) . The cap structure and the poly(A) tail represented key elements for the cap-dependent translation pathway. An interaction between poly(A)-binding protein bound at the 3 0 end of the messenger and eIF4G bound at the 5 0 end resulted in circularization of the mRNA. The cap and poly(A) tail, which facilitated the recruitment of eIFs, allowed for RNA circularization 16 and induced stimulation and regulation of translation. It has been suggested 0 UTR spanning the LucF coding sequence. DNA templates for transcription are PCR-generated from pGEM-T/5UTR-LucF-3UTR using specific primers.
In vivo imaging of translated RNAs K Pinel et al that circularization also facilitated the recycling of ribosomes, allowing almost immediate entry to the next initiation phase after termination of protein synthesis. 16, 26 Finally, circularization was important in maintaining the physical integrity of mRNA. 27 Because the cap-LucF-polyA RNAs used in the present study had a very short 5 0 UTR and did not contain the HCV IRES motif, we hypothesized that they may be exclusively translated by the capdependent pathway.
RNA containing a viral IRES but lacking a cap and poly(A) tail was also translated in vivo after EP. The 5 0 UTR that we used contained sequences from HCV required for IRES activity, specifically sequences located between domains II and IV. 28 IRES-LucF-3UTR RNAs were translated and BLI signal was detectable for B3 days post delivery. A dose effect was observed between the lowest and the two higher quantities of IRES-LucF-3UTR delivery, suggesting that LucF translation was not saturated. This difference regarding cap-LucF-polyA RNAs may be due to high IRES-LucF-3UTR RNA instability; thus, increasing the number of delivered molecules makes a larger pool of RNAs available for translation. The poly(A) tail had a protective role against RNA degradation, and this structure was previously demonstrated to enhance translation driven by an IRES in picornaviral RNAs. 29 Therefore, we also synthesized IRES-LucF-3UTR-translated RNAs with a poly(A) tail. The in vivo translation efficiencies of IRES-LucF-3UTR and IRES-LucF-polyA RNAs were similar in magnitude ( Figures 3, 4 and 5a ) but the duration of detectable BLI signal was longer for the polyadenylated form ( Figures 3, 4 and 5b) . These results suggest that the poly(A) tail . In this plot, the whiskers extend to the largest and smallest data points, the box extends from the upper quartile to the lower quartile and is crossed by a line at the median of the data.
In vivo imaging of translated RNAs K Pinel et al increases the stability of RNAs in vivo, even in the absence of the cap structure. Furthermore, these findings corroborate that the interaction of the poly(A) tail with the cap was stimulatory, but not essential, for translation. 16 LucF activity was detected longer after delivery of polyadenylated RNA when compared with IRES-LucF-3UTR RNA. This was likely due to RNA protection against RNases provided by the poly(A) tail. Both the 5 0 and 3 0 untranslated region of HCV also contained several double-stranded secondary structure such as helices and hairpins. 28, 30 Double-stranded viral RNA was known to activate the interferon pathway through TLR3 or intracytosolic RNA helicases such as RIG-I/MDA5, inhibiting viral expression particularly through the activation of RNase L. Therefore, the innate immune response could differentially impact RNA stability through the cap structure, HCV IRES, 3 0 untranslated region of HCV and poly(A) tail components. 31 Alternatively, differences in innate immune responses according to the different RNA types could be exploited to modulate for RNA-based vaccine strategy.
IRES-dependent translation had important roles at specific times when cap-dependent translation was severely repressed. 17, 18 In a strong mitotic context, a switch from cap-dependent to IRESdependent translation has been demonstrated. 18, 19 For example, the translational activity of the HCV IRES was greatest in cells that were actively dividing. 32 In differentiated tissues, cap-LucF-polyA RNAs provided the highest rate of protein expression, but, in a highproliferation context such as cancer, it might be more efficient to choose RNAs containing IRESs to express the therapeutic protein.
Among other advantages, the synthesis of IRES-RNAs was easier and less expensive than capped/polyadenylated RNAs. Finally, although it has not been tested in this study, the use of RNAs that were both capped/polyadenylated and that contained an IRES could be even more efficient. Alternatively, whereas circularization of the capped/ polyadenylated RNAs may have a significant role in RNA stability through protection of extremities, increasing the half-life of the mRNA and thus its translation efficiency and duration, the use of circularized IRES-RNAs could be tested 33 to bring together expression efficiency and cost-effective production.
The large variation in both the rate of translation of RNAs and the duration of expression remained a major limitation to the potential use of RNAs for therapeutic purposes. Very large differences in the rate of LucF expression have been observed with cap-LucF-polyA, with expression levels ranging up to 10 times more. Variability could be partially due to the EP delivery method; although already known to be efficient for DNA, reports on optimization for RNA delivery were absent.
These experiments demonstrate that RNAs were efficient tools for transient expression of proteins in vivo. RNA vectors might challenge DNA for many therapeutic purposes, especially applications that require 1 or 2 weeks of protein expression or in cases where integration into the genome should be absolutely avoided. RNAs were versatile tools, and by flanking the coding sequence with different biochemical features, both translation efficiency and duration could be adapted to achieve a wide range of therapeutic goals and physiopathological situations, addressing unmet medical needs.
MATERIALS AND METHODS Animals
The project was approved by the ethical committee of Bordeaux (CEEA50) under agreement A50120194. C57BL/6 mice (6 to 10 weeks old) were purchased from Charles River Laboratories (Lyon, France). For all experimental procedure including shaving, EP and imaging, animals (n ¼ 51) were anesthetized with 2% isoflurane (Belamont, Nicholas Piramal, London, UK) in air. 12 molecules (n ¼ 3). In this plot the whiskers extend to the largest and smallest data points, the box extends from the upper quartile to the lower quartile and is crossed by a line at the median of the data (**P between 0.01 and 0.05, *P between 0.05 and 0.1; heteroscedastic, one-tailed t-test).
In vivo imaging of translated RNAs K Pinel et al
RNA synthesis
Plasmid construction. The basic plasmid construct pGEM-T/5UTR-EGFP-3UTR 34 contained the 5 0 UTR (including the first 27 nt of the core protein coding sequence) and the 3 0 untranslated region sequence from the Con1 HCV strain flanking the EGFP gene. pGEM-T/5UTR-LucF-3UTR was generated by replacing EGFP with the LucF coding sequence amplified by PCR with BamHI and XbaI sites.
Generation of DNA templates. Three DNA templates for T7 RNA polymerase were PCR-generated, starting with pGEM-T/5UTR-LucF-3UTR, Taq Phusion DNA polymerase (Ozyme, Saint-Quentin Yvelines, France) and selected primers containing the T7 promoter (Figure 1) . The 5UTR-LucF-3UTR DNA template was generated using T7-5UTRStart (5 0 -AATACGACTCACTA TAGGGGCCAGCCCCCGATTGGGGGCG-3 0 ) and 3UTR-Stop (5 0 -ACTTGATCTG CAGAGAGGCCAG-3 0 ) primers. The 5UTR-LucF DNA template was synthesized using T7-5UTRStart and LucF-Stop (5 0 -GGCCTGGAGTGTTTAG CTCCC-3 0 ) primers. The LucF DNA template was generated using T7-cap (5 0 -TAATACGACTCACTATAGGGCCCCGGGAGGTCTCGTAGACC-3 0 ) and LucFStop primers.
The size of DNA templates was then verified by migration on 1% agarose gels and purified on a MicroSpin S400 HR column (GE Healthcare, Amersham, UK).
In vitro transcription. In vitro transcription was performed using the MEGAscript T7 kit (Life Technologies, Carlsbad, CA, USA) using 1 mg of PCR 12 molecules (n ¼ 3). In this plot, the whiskers extend to the largest and smallest data points, the box extends from the upper quartile to the lower quartile and is crossed by a line at the median of the data (***Po0.1; **P between 0.01 and 0.05; heteroscedastic, one-tailed t-test). 12 RNA molecules (**P between 0.01 and 0.05, *P between 0.05 and 0.1; heteroscedastic, one-tailed t-test).
In vivo imaging of translated RNAs K Pinel et al template (4 h; 37 1C). DNA templates were then digested with DNase I (15 min; 37 1C). After acidic phenol and chloroform extraction, RNAs were precipitated with isopropanol. Purity and integrity of the transcription products were determined using an aliquot for capillary electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa-Clara, CA, USA). RNA was kept frozen ( À 80 1C) until use.
Capping method. Cap-LucF-polyA RNAs were capped using the ScriptCap system (Epicentre, Madison, WI, USA) according to the manufacturer's instructions. Briefly, RNA (75 mg) was denatured by heat (65 1C; 10 min). Then, capping reaction (1 h; 37 1C) was performed in capping buffer (100 ml) containing GTP (1 mM), S-adenosyl methionine (0.1 mM), Scriptguard (2.5 ml) and ScriptCap enzyme mix (4 ml).
Polyadenylation method. Cap-LucF-polyA and IRES-LucF-polyA were polyadenylated using the A-Plus Poly(A) Polymerase Tailing Kit (Epicentre) according to the manufacturer's protocol. Final quality assessment of RNAs is performed by capillary electrophoresis (Agilent 2100 Bioanalyzer).
RNA EP
RNAs were diluted in RNase-free phosphate-buffered saline (10 ml) and injected intra-dermally on the left leg. Transcutaneous electric pulses were applied immediately using two parallel plaque electrodes (0.5 cm apart) placed on each side of the injected area. A conductive gel was used to ensure good contact. Electric pulses were generated by an Electro Cell S20 (BETA-tech, Saint-Orens-de-Gameville, France) electropulsator using runs of eight square-waved pulses (1 Hz; 20 ms; 200 V cm À 1 ) for each experiment.
In vivo BLI
BLI was performed at Vivoptic (Bordeaux University) using a NightOWLII-LB 983 system (Berthold Technologies, Bad-Wildbad, Germany). Mice received an intra-peritoneal injection of D-luciferin (Promega, Madison, WI, USA, 2.9 mg in 100 ml phosphate-buffered saline) and were sedated 7 min later. Bioluminescence images (2 min, 4 Â 4 binning) and photographs (100 ms) were taken 10 min after luciferin injection. The bioluminescence signal was analyzed using Indigo software (Berthold Technologies) by placing a small region of interest on the leg. The mean light intensity (in photons s À 1 mm À 2 ) was measured within this region of interest.
Statistical analysis
Statistical significance (***Po0.01, **P between 0.01 and 0.05, *P between 0.05 and 0.1) was calculated using unpaired, heteroscedastic, one-tailed t-test.
